the extenet study & management of her2 breast cancer
Published 4 years ago • 142 plays • Length 2:48Download video MP4
Download video MP3
Similar videos
-
5:24
the extenet trial
-
6:40
her2 breast cancer: managing patients on t-dm1
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
4:54
understanding the extenet trial
-
1:05:11
ask the expert: early-stage her2-positive breast cancer with adrienne waks, md
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
0:59
sequencing her2-targeted therapies in breast cancer
-
3:22
managing recurrent metastatic er /her2- breast cancer
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
1:14:37
individualizing the selection of first-line therapy for patients with hr-positive metastatic bc
-
14:24
practical management of early stage her2 breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
7:45
trastuzumab emtansine in her2 breast cancer
-
5:46
use of her2-targeted therapy in breast cancer
-
7:52
introduction and overview of her2-targeted therapies in breast cancer
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
5:37
r/r her2 metastatic breast cancer: neratinib ae management
-
5:44
perioperative treatment of early stage her2 breast cancer
-
4:30
tucatinib for the treatment of her2 breast cancer
-
8:49
case study: treating her2-positive metastatic breast cancer, part i
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies